What is the Return on Assets (ROA) of Propanc Biopharma this year?
The Return on Assets (ROA) of Propanc Biopharma is -51.83 undefined this year.
Propanc Biopharma ROA 2024
Propanc Biopharma ROA
-51.83
Propanc Biopharma Dividend yield
Ticker
PPCB
ISIN
US74346N4043
WKN
A2QJDP
In 2024, Propanc Biopharma's return on assets (ROA) was -51.83, a 59.21% increase from the -32.55 ROA in the previous year.
Propanc Biopharma Aktienanalyse
What does Propanc Biopharma do?
Propanc Biopharma Inc. is a biotechnology company focused on the treatment of cancer. It was founded in 2007 in Australia and is now headquartered in Delaware, USA. The company is listed on the Australian stock exchange and the OTC Pink market in the USA. Propanc Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Propanc Biopharma's Return on Assets (ROA)
Propanc Biopharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Propanc Biopharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Propanc Biopharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Propanc Biopharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Propanc Biopharma Stock
What was the ROA of Propanc Biopharma compared to the previous year?
The ROA of Propanc Biopharma has increased by 59.21% compared to the previous year.
What consequences do high ROA have for investors of Propanc Biopharma?
A high ROA is advantageous for investors of Propanc Biopharma, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Propanc Biopharma?
A low ROA can be unfavorable for investors of Propanc Biopharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Propanc Biopharma affect the company?
An increase in ROA of Propanc Biopharma can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Propanc Biopharma impact the company?
A reduction in the ROA of Propanc Biopharma can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Propanc Biopharma?
Some factors that can influence the ROA of Propanc Biopharma include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Propanc Biopharma important for investors?
The ROA of Propanc Biopharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Propanc Biopharma take to improve ROA?
To improve ROA, Propanc Biopharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Propanc Biopharma pay?
Over the past 12 months, Propanc Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Propanc Biopharma is expected to pay a dividend of 0 USD.
What is the dividend yield of Propanc Biopharma?
The current dividend yield of Propanc Biopharma is .
When does Propanc Biopharma pay dividends?
Propanc Biopharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Propanc Biopharma?
Propanc Biopharma paid dividends every year for the past 0 years.
What is the dividend of Propanc Biopharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Propanc Biopharma located?
Propanc Biopharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von Propanc Biopharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Propanc Biopharma from 6/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/10/2024.
When did Propanc Biopharma pay the last dividend?
The last dividend was paid out on 6/10/2024.
What was the dividend of Propanc Biopharma in the year 2023?
In the year 2023, Propanc Biopharma distributed 0 USD as dividends.
In which currency does Propanc Biopharma pay out the dividend?
The dividends of Propanc Biopharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Propanc Biopharma
Our stock analysis for Propanc Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Propanc Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Propanc Biopharma Revenue
- Propanc Biopharma Net Income
- Propanc Biopharma P/E
- Propanc Biopharma P/S
- Propanc Biopharma EBIT
- Propanc Biopharma Dividend
- Propanc Biopharma Stocks
- Propanc Biopharma Market capitalization
- Propanc Biopharma Debt
- Propanc Biopharma Liabilities
- Propanc Biopharma Equity
- Propanc Biopharma AAQS
- Propanc Biopharma Employees
- Propanc Biopharma ROE
- Propanc Biopharma ROA
- Propanc Biopharma ROCE
